Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Webinar Outcomes Survey

Thank you for completing the Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Webinar. Please take a few minutes to answer the following questions.

What is your profession? Other (if other please enter)

How has your confidence changed in applying new knowledge or skills since you completed the Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Webinar? *

	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
I can explain the benefits of statin therapy for people with HIV.	I can explain the benefits of statin therapy for people with HIV. - Strongly disagree	I can explain the benefits of statin therapy for people with HIV. - Disagree	I can explain the benefits of statin therapy for people with HIV. - Neutral	I can explain the benefits of statin therapy for people with HIV. - Agree	I can explain the benefits of statin therapy for people with HIV. - Strongly agree
I can describe the risk of cardiovascular disease in people with HIV.	I can describe the risk of cardiovascular disease in people with HIV. - Strongly disagree	I can describe the risk of cardiovascular disease in people with HIV. - Disagree	I can describe the risk of cardiovascular disease in people with HIV. - Neutral	I can describe the risk of cardiovascular disease in people with HIV. - Agree	I can describe the risk of cardiovascular disease in people with HIV. - Strongly agree
I can evaluate patients with HIV for statin therapy initiation.	I can evaluate patients with HIV for statin therapy initiation. - Strongly disagree	I can evaluate patients with HIV for statin therapy initiation. - Disagree	I can evaluate patients with HIV for statin therapy initiation. - Neutral	I can evaluate patients with HIV for statin therapy initiation. - Agree	I can evaluate patients with HIV for statin therapy initiation. - Strongly agree
I can use shared decision-making in offering statin therapy to people with HIV in our clinic.	I can use shared decision-making in offering statin therapy to people with HIV in our clinic. - Strongly disagree	I can use shared decision-making in offering statin therapy to people with HIV in our clinic. - Disagree	I can use shared decision-making in offering statin therapy to people with HIV in our clinic. - Neutral	I can use shared decision-making in offering statin therapy to people with HIV in our clinic. - Agree	I can use shared decision-making in offering statin therapy to people with HIV in our clinic. - Strongly agree

Were you able to implement practice changes based on what you learned from the Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Webinar? *

Yes

No (Why not?)

Were you able to implement practice changes based on what you learned from the Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Webinar? No (Why not?)

What specific practice changes did you implement? (Select all that apply) *

Used shared decision-making with patients when offering statin therapy.

Evaluated patients with HIV for statin therapy.

Offered statin therapy to people with HIV according to the guidelines.

Implemented the new statin therapy recommendations with the healthcare team.

Which changes that you implemented impacted the performance of the health care team at your institution? (Select all that apply) *

Used shared decision-making with patients when offering statin therapy.

Evaluated patients with HIV for statin therapy.

Offered statin therapy to people with HIV according to the guidelines.

Implemented the new statin therapy recommendations with the healthcare team.

How did the practice changes improve patient health outcomes? (Select all that apply) *

Patients with HIV learned about the risks of cardiovascular disease and the benefits of statin therapy.

Patients with HIV were evaluated for statin therapy initiation.

Used shared decision-making to initiate statin therapy to people with HIV in our clinic.

Patients on statin therapy now have a decreased risk of developing cardiovascular disease.

Other (Please Specify)

How did the practice changes improve patient health outcomes? (Select all that apply) Other (Please Specify)

What barriers to change did you encounter? (Select all that apply) *

What barriers to change did you encounter? (Select all that apply) Other (please specify)

You are here

Statin Therapy & People With HIV: New Guidance to Prevent Cardiovascular Disease Webinar Outcomes Survey